增强HIV进入途径的防御：黏膜免疫与天然免疫。
Improving defences at the portal of HIV entry: mucosal and innate immunity.
作者信息
Shattock Robin J, Haynes Barton F, Pulendran Bali, Flores Jorge, Esparza José
机构信息
St George's, University of London, London, United Kingdom.
出版信息
PLoS Med. 2008 Apr 1;5(4):e81. doi: 10.1371/journal.pmed.0050081.
Abstract
The authors discuss the key scientific issues in mucosal and innate immunity related to immune protection against HIV infection.
摘要
作者们讨论了与针对HIV感染的免疫保护相关的黏膜和固有免疫中的关键科学问题。
相似文献
1
Improving defences at the portal of HIV entry: mucosal and innate immunity.增强HIV进入途径的防御：黏膜免疫与天然免疫。
PLoS Med. 2008 Apr 1;5(4):e81. doi: 10.1371/journal.pmed.0050081.
2
Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007.黏膜免疫与艾滋病疫苗。2007年10月28 - 30日国际研讨会报告
Vaccine. 2008 Jul 29;26(32):3969-77. doi: 10.1016/j.vaccine.2008.04.051. Epub 2008 May 8.
3
Induction of innate immunity in control of mucosal transmission of HIV.诱导固有免疫控制 HIV 的黏膜传播。
Curr Opin HIV AIDS. 2011 Sep;6(5):398-404. doi: 10.1097/COH.0b013e3283499df7.
4
Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development.艾滋病疫苗转化研究迷你综述系列：利用固有免疫研发艾滋病疫苗
Clin Exp Immunol. 2009 Aug;157(2):174-80. doi: 10.1111/j.1365-2249.2009.03928.x.
5
Protecting the initial site of viral entry: an alternative HIV vaccine target.保护病毒进入的初始部位：一种替代性的HIV疫苗靶点。
Expert Rev Vaccines. 2011 Sep;10(9):1253-6. doi: 10.1586/erv.11.98.
6
Use of adenovirus in vaccines for HIV.腺病毒在HIV疫苗中的应用。
Handb Exp Pharmacol. 2009(188):275-93. doi: 10.1007/978-3-540-71029-5_13.
7
In pursuit of an HIV vaccine: an interview with Andrew McMichael.追寻艾滋病疫苗：对安德鲁·麦克迈克尔的采访
BMC Biol. 2013 May 21;11:60. doi: 10.1186/1741-7007-11-60.
8
[The role of dendritic cells in the infection by HIV and HCV].[树突状细胞在人类免疫缺陷病毒和丙型肝炎病毒感染中的作用]
Medicina (B Aires). 2007;67(1):63-70.
9
DCs for HIV vaccine?用于HIV疫苗的树突状细胞？
Nat Rev Microbiol. 2007 Mar;5(3):172. doi: 10.1038/nrmicro1634.
10
Honing the T cell response to HIV: Turning off the noise.优化针对HIV的T细胞反应：消除干扰。
EBioMedicine. 2021 Feb;64:103217. doi: 10.1016/j.ebiom.2021.103217. Epub 2021 Jan 28.
引用本文的文献
1
Metronidazole Treatment Failure and Persistent BV Lead to Increased Frequencies of Activated T- and Dendritic-Cell Subsets.甲硝唑治疗失败与持续性细菌性阴道病导致活化T细胞和树突状细胞亚群频率增加。
Microorganisms. 2023 Oct 27;11(11):2643. doi: 10.3390/microorganisms11112643.
2
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment.通过 CXCR4 结合控制 pDCs 中的 TLR7 介导的 I 型 IFN 信号转导——狼疮治疗的新靶点。
Sci Adv. 2019 Jul 10;5(7):eaav9019. doi: 10.1126/sciadv.aav9019. eCollection 2019 Jul.
3
The Role of Defensins in HIV Pathogenesis.防御素在 HIV 发病机制中的作用。
Mediators Inflamm. 2017;2017:5186904. doi: 10.1155/2017/5186904. Epub 2017 Aug 3.
4
Recent Insights into the HIV/AIDS Pandemic.对艾滋病毒/艾滋病大流行的最新见解
Microb Cell. 2016 Sep 5;3(9):451-475. doi: 10.15698/mic2016.09.529.
5
Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination.视黄醛脱氢酶2作为DNA疫苗接种期间增强黏膜免疫的分子佐剂。
Vaccine. 2016 Nov 4;34(46):5629-5635. doi: 10.1016/j.vaccine.2016.09.013. Epub 2016 Sep 23.
6
Effects of Female Sex Hormones on Susceptibility to HSV-2 in Vaginal Cells Grown in Air-Liquid Interface.女性性激素对气液界面培养的阴道细胞中单纯疱疹病毒2型易感性的影响。
Viruses. 2016 Aug 30;8(9):241. doi: 10.3390/v8090241.
7
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques.人源非中和性HIV-1包膜单克隆抗体可限制恒河猴黏膜感染SHIV期间初始病毒的数量。
PLoS Pathog. 2015 Aug 3;11(8):e1005042. doi: 10.1371/journal.ppat.1005042. eCollection 2015 Aug.
8
HIV vaccine research: the challenge and the way forward.HIV 疫苗研究：挑战与前进方向。
J Immunol Res. 2015;2015:503978. doi: 10.1155/2015/503978. Epub 2015 Mar 15.
9
Aggregate complexes of HIV-1 induced by multimeric antibodies.多聚体抗体诱导的HIV-1聚集复合物。
Retrovirology. 2014 Oct 2;11:78. doi: 10.1186/s12977-014-0078-8.
10
Organizing the HIV vaccine development effort.组织艾滋病病毒疫苗研发工作。
Curr Opin HIV AIDS. 2013 Sep;8(5):369-75. doi: 10.1097/COH.0b013e328363f5b6.
本文引用的文献
1
Resolution of de novo HIV production and trafficking in immature dendritic cells.新生HIV在未成熟树突状细胞中的产生及运输的消退
Nat Methods. 2008 Jan;5(1):75-85. doi: 10.1038/nmeth1137. Epub 2007 Dec 2.
2
Lymphocyte tracking and interactions in secondary lymphoid organs.次级淋巴器官中的淋巴细胞追踪与相互作用。
Inflamm Res. 2007 Oct;56(10):391-401. doi: 10.1007/s00011-007-7017-2.
3
A near-infrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses.一种用于多视角体内成像和白细胞免疫反应定量分析的近红外细胞追踪试剂。
PLoS One. 2007 Oct 24;2(10):e1075. doi: 10.1371/journal.pone.0001075.
4
Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids.肠道中的归巢印记与免疫调节：树突状细胞和视黄醇的作用
Inflamm Bowel Dis. 2008 Feb;14(2):275-89. doi: 10.1002/ibd.20280.
5
Fc receptor but not complement binding is important in antibody protection against HIV.Fc受体而非补体结合在抗体抗HIV保护中起重要作用。
Nature. 2007 Sep 6;449(7158):101-4. doi: 10.1038/nature06106.
6
HIV/AIDS: allied responses.艾滋病毒/艾滋病：联合应对措施
Nature. 2007 Sep 6;449(7158):29-30. doi: 10.1038/449029a.
7
Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen.基于纳米颗粒的生物条形码扩增检测法（BCA）用于灵敏且早期检测1型人类免疫缺陷病毒衣壳（p24）抗原
J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):231-7. doi: 10.1097/QAI.0b013e31814a554b.
8
Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshop.调节性T细胞（Treg）与艾滋病：2006年9月7 - 8日研讨会综述
AIDS Res Hum Retroviruses. 2007 Jul;23(7):945-52. doi: 10.1089/aid.2006.0259.
9
Innate signaling and regulation of Dendritic cell immunity.树突状细胞免疫的固有信号传导与调节
Curr Opin Immunol. 2007 Aug;19(4):435-40. doi: 10.1016/j.coi.2007.05.006. Epub 2007 Jul 12.
10
Humoral immunity to HIV-1: neutralization and beyond.针对HIV-1的体液免疫：中和作用及其他。
J Intern Med. 2007 Jul;262(1):5-25. doi: 10.1111/j.1365-2796.2007.01819.x.
Zotero 插件